老年急性心肌梗死静脉溶栓治疗的观察

目的 本文旨在观察老年急性心肌梗死后静脉溶栓疗效。方法 对60岁以上AMI患者201例,静脉溶栓治疗组86例,与未溶栓组115例进行比较。结果 观察溶栓组再通率36％,而溶栓后心律失常发生率明显升高,梗死后心绞痛、心源性休克发生例数明显减少。结论 溶栓治疗有益老年AMI患者的临床预后,但延迟溶栓治疗时间和老年人冠状动脉复杂病变可能影响溶栓疗效。     

静脉溶栓治疗急性心肌梗死52例临床观察

目的总结急性心肌梗死的静脉溶栓治疗。方法通过近3年我院收治的52例ST段抬高急性心肌梗死患者给予静脉溶栓治疗，并行规范化治疗，大大地提高了抢救成功率，缩短了住院时间，减少了死亡率。     

静脉溶栓治疗100例老年急性心肌梗死患者的护理措施

目的探讨静脉溶栓治疗老年急性心肌梗死患者应采取的护理措施及其临床应用效果。方法按随机数字表法将我院2012年1月—2014年6月收治的100例老年急性心肌梗死患者分为对照组和观察组,每组50例。两组均行静脉溶栓治疗,对照组给予常规护理,观察组给予针对性护理,比较两组患者的并发症及血管再通率。结果对照组护理后发生严重心律失常9例,心力衰竭12例,再梗死10例;观察组护理后发生严重心律失常2例,心力衰竭2例,再梗死6例,观察组严重心理失常及心力衰竭的发生率明显低于对照组,比较差异具有统计学意义（P〈0.05）,再梗死发生率比较差异无统计学意义（P〉0.05）。对照组血管再通39例,占78%;观察组血管再通14例,占28%,组间比较差异具有统计学意义（P〈0.05）。结论老年急性心肌梗死患静脉溶栓治疗时实施针对溶栓的特殊护理可降低并发症发生率和死亡率,具有临床推广价值。     

老年急性心肌梗死静脉溶栓的护理

目的探讨老年急性心肌梗死患者静脉溶栓的观察与护理方法，总结护理经验。方法收集了近3年的83例老年急性心肌梗死患者的完整病例，采用了回顾性资料的统计方法。结果83例病人，71人痊愈出院，10人好转出院，2例病人死亡。结论对于老年急性心肌梗死患者的静脉溶栓，应按医嘱准确及时输入溶栓药物，并在用药期间密切观察病情，及时发现异常倾向并积极配合抢救。同时要做好各项治疗护理，预防并发症，使病人及早康复。     

急性心肌梗死静脉溶栓治疗的观察和护理

目的 探讨急性心肌梗死静脉溶栓治疗的急诊护理,提高急性心肌梗死的救治成功率.方法 回顾性分析我院急诊科2005年1月至2013年1月收治的236例进行静脉溶栓的急性心肌梗死患者的救治资料,分析总结早期的诊治和护理经验.结果 236例急性心肌梗死患者经过积极溶栓抢救和精心护理,溶栓时、溶栓后各种并发症得到有效预防及控制,静脉溶栓成功194例,成功率82.2％.结论 静脉溶栓的急性心肌梗死患者积极治疗的基础上配合精心的护理,可及时地发现以及预防各种并发症,从而提高急性心肌梗死患者溶栓治疗的成功率.     

浅谈急性心肌梗死的早期静脉溶栓治疗观察

急性心肌梗死是冠状动脉突然发生阻塞．局部心肌由于血供中断而发生缺血坏死。静脉溶栓疗法能使急性心肌梗死的预后完全改观．而且给药方便,已成为急性心肌梗死治疗中最重要的方法之一。     

静脉溶栓治疗急性心肌梗死的监护

急性心肌梗死是临床常见的急症,死亡率高,主要病因为冠状动脉内血栓形成,尿激酶用于溶栓已在临床广泛开展.它可直接激活纤溶酶原,使之转变成纤溶酶,将血栓成分纤维蛋白分解为可溶性物质而被清除.我科近几年溶栓治疗80余例急性心肌梗死患者疗效显著,对于护理工作中监护病情的观察应做为重点,现谈体会如下.     

静脉溶栓治疗急性心肌梗死护理体会

目的探讨急性心肌梗死(AMI)患者静脉溶栓治疗的护理方法。方法对56例发病在6 h内的急性心肌梗死患者,将尿激酶(UK)150万U加入100 ml生理盐水中,使用输液泵在30min内静脉泵入。结果本组冠状动脉再通42例,再通率75.0%;未通14例,未通率25.0%。结论对急性心肌梗死患者及时溶栓治疗并在溶栓中、溶栓后进行有效的护理和严密观察,可提高溶栓治疗的成功率,促进患者康复,减少并发症的发生,提高患者的生活质量。     

急性心肌梗死静脉溶栓治疗的护理体会

目的：讨论急性心肌梗死静脉溶栓治疗的护理体会,减少并发症,降低死亡率,促进患者早日康复。方法：对11例急性心肌梗死患者进行静脉溶栓治疗,同时配合肝素抗凝治疗及密切观察病情变化,做好心理护理,收到了满意的效果。结论：急性心肌梗死静脉溶栓治疗前后的护理至关重要。     

急性心肌梗死静脉溶栓治疗的进展

急性心肌梗死(AMI)溶栓治疗是近几年AMI治疗的重大进展。80年代初开展了AMI冠脉溶栓治疗,随后静脉溶栓治疗在世界各地普遍开展。AMI静脉溶栓治疗是在AMI发生后迅速经静脉注射溶栓剂,使引起心肌梗死的冠脉内血栓溶解,阻塞的动脉重新开放。恢复血液灌注,从而挽救一部分濒     

80岁以上高龄老人急性心肌梗死溶栓治疗的临床探讨

目的 探讨80岁以上高龄老人ST段抬高的急性心肌梗死(AMI)静脉溶栓治疗的疗效和安全性。方法 使用尿激酶(UK)静脉溶栓治疗80岁以上的AMI患9例。观察疗效及随访资料。结果 间接指标表明9例80岁以上的高龄老人AMI静脉溶栓成功，梗死相关血管(IRA)再通。结论 80岁以上的高龄老人AMI在无绝对禁忌证时，采用个体化给药进行静脉溶栓是相对安全、有效的。     

80岁以上高龄老人急性心肌梗死溶栓治疗的临床探讨

目的探讨80岁以上高龄老人ST段抬高的急性心肌梗死(AMI)静脉溶栓治疗的疗效和安全性.方法使用尿激酶(UK)静脉溶栓治疗80岁以上的AMI患者9例.观察疗效及随访资料.结果间接指标表明9例80岁以上的高龄老人AMI静脉溶栓成功,梗死相关血管(IRA)再通.结论 80岁以上的高龄老人AMI在无绝对禁忌证时,采用个体化给药进行静脉溶栓是相对安全、有效的.     

Acute myocardial infarction in elderly patients

Background: Age is the most important determinant of outcome for patients with acute coronary syndromes (ACS) and ischemic heart disease is the leading cause of death among elderly patients. Aim: To determine the epidemiologic particularities, the clinical presentation, and the treatment of Acute Myocardial Infarction (AMI) in patients over 65 years. Methods: One hundred patients >65 years of age with myocardial infarction were hospitalized in intensive care of cardiologic unit of Military Hospital of Tunis between 2000 and 2008. Clinical characteristics, reperfusion therapy and outcomes of in-hospital period and for one year follow-up were seen for every patient. Results: The mean age of our population was 77 years. Sex-ratio was 3/1.Our population was divided into tow groups; patients aged between 65 and 75 years (48 patients) and those aged more than 75 years (52 patients). Only 44 % of our patients had arrived at the hospital within the first 12 hours. STEMI was found in 65 % of our patients. At admission, 40 % had congestive heart failure (3 Killip II), 10 % were in cardiogenic shock. Urgent reperfusion therapy was given to 58 % of our patients; 33% received a thrombolytic therapy and 25 % were allocated to primary PCI. During in-hospital period, 40 % have developed congestive heart failure, 20 % have had a cardiogenic shock and 12 % were died. All these events were more frequent in patients aged over 75 years and reperfusion therapy was associated with best outcome. Conclusion: In our study invasive treatment such as fibrinolysis and PCI was associated to better outcome in acute period and at 12 months of follow up in elderly patients treated for AMI.     

Observations on the current status concerning the epidemic of acute myocardial infarction

After the mortality from acute myocardial infarction had reached its peak in 1972, a decrease started which by now, taking into account the increase and the greying of the population, already amounts to 33%. Nevertheless, in 1987 as many as 19,168 deaths were still recorded. When after World War II the mortality rose, it was found that the victims included a growing proportion of younger persons. Currently, however, the decrease of mortality in general is most pronounced among the younger age groups. Among the patients treated in hospital, mortality shows an evenly distributed decrease. The admission rates from the populations of commuter municipalities and from rural areas are relatively low, those from medium-sized municipalities with an urban character, relatively high.     

探讨老年人急性心肌梗死的临床特点及分析

我们对老年急性心肌梗死(AMI)患者与同期非老年急性心肌梗死患者临床资料进行分析,讨论中老年人心梗以下壁为多见,复发性心梗尤多.总之,对老年患者我们不能局限于症状的诊断和处理,尤其对合并糖尿病、高血压病的高危患者应做进一步动态观察分析,早期行筛选检查,了解心电图及心肌酶谱的动态改变情况,并对治疗效果做精确分析,及时查明病因,避免漏诊或误诊,延误治疗时机.     

老年冠心病患者并发急性心肌梗死危险因素分析

目的 探讨老年冠心病患者并发急性心肌梗死（AMI）的危险因素,为采取相应的预防控制措施提供参考。方法 于2013年10月-2016年10月在齐齐哈尔医学院附属第三医院随机抽取心内科就诊的老年冠心病并发AMI患者73例作为AMI组,另抽取该科室同期就诊的老年单纯冠心病患者132例作为非AMI组,采用多因素logistic回归模型分析老年冠心病患者并发AMI危险因素。结果 AMI组老年冠心病患者血清高敏C反应蛋白（hs-CRP）和血肌酐（SCr）水平分别为（7.02±1.83） mmol/L和（94.23±19.23） mmol/L,均高于非AMI组老年冠心病患者的（4.56±0.89） mmol/L和（88.27±16.06） mmol/L,差异均有统计学意义（均P<0.05）;多因素logistic回归分析结果显示,吸烟、高血压、糖尿病、有心血管病家族史和hs-CRP水平较高是老年冠心病患者并发AMI的独立危险因素。结论 吸烟、高血压、糖尿病、有心血管病家族史和hs-CRP水平较高均会增加老年冠心病患者发生AMI的风险。     

急性心肌梗死静脉溶栓治疗的进展

急性心肌梗死(AMI)溶栓治疗是近几年AMI治疗的重大进展.80年代初开展了AMI冠脉溶栓治疗,随后静脉溶栓治疗在世界各地普遍开展.AMI静脉溶栓治疗是在AMI发生后迅速经静脉注射溶栓剂,使引起心肌梗死的冠脉内血栓溶解,阻塞的动脉重新开放,恢复血液灌注,从而挽救一部分濒死的心肌,缩小梗死面积,维护心脏功能,降低AMI病死率及改善预后.此疗法方便、及时,现已成为AMI的经典疗法.本文就近几年国内外有关AMI静脉溶栓治疗研究进展介绍如下.     

Post-acute service use following acute myocardial infarction in the elderly

This exploratory study examined the extent to which factors beyond characteristics of the patient, such as discharging hospital attributes and State factors, contributed to variations in post-acute services use (PASU) in a cohort of elderly Medicare patients following acute myocardial infarction (AMI). Thirty-seven percent of this cohort received PAS within 30 days of discharge and home health care was the most common type of service used. Patient severity of illness at hospital discharge, for-profit ownership of the discharging hospital, and discharging hospital provision of home health services were shown to be important predictors of PASU. After adjusting for many patient and hospital characteristics, however, variation in PASU remained across States.